Article & News

Gubba Group
India’s problem of overtreatment, overmedication

Why in the NewsModern medicine’s growing power to test and treat is increasingly turning into overtreatment and overmedication: tests, medicines and procedures a patient does

Gubba Group
Unregulated use of GM: A cautionary tale

The loser is not just the organised seed industry. Sales of “legal” Bt cotton hybrid seeds have fallen from 59.6 million to 46.3 million packets

Gubba Group
Aurobindo Pharma: Strong dose of growth opportunities

With key projects moving into commercial production, the drugmaker has stronger near-term growth visibility and also a long runwayAurobindo Pharma has developed multiple growth opportunities